Bioligands bought by investors and UK's Bridge BioResearch
Preclinical molecular biology services firm BioLigands has changed ownership.
Preclinical molecular biology services firm BioLigands has changed ownership.
Xoma will further reduce its manufacturing capacity with plans to cut a third of its workforce.
Delivery tech firm MonoSol Rx and nanoparticle excipient developer Midatech have set up a new diabetes-focused joint venture (JV).